Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8854910 | 0.97 | — | — | |
| SCHEMBL1081392 | 0.97 | HRH3 (0.39) | HRH3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL87801 | 0.97 | — | — | |
| SCHEMBL486492 | 0.97 | — | — | |
| Bromide SCHEMBL10332289 | 0.94 | HRH3 (0.38) | HRH3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| Bromide SCHEMBL1471663 | 0.94 | HRH3 (0.38) | HRH3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| Iodide SCHEMBL28911088 | 0.94 | SMN1; SMN2 (0.38) | HRH3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| Hydrochloric Acid SCHEMBL28067318 | 0.94 | SIGMAR1 (0.39) | HRH3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL1489209 | 0.94 | — | — | |
| SCHEMBL88222 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101027311-A | Resorcinol carbonate-based phosphate compounds as flame retardants | INDSPEC CHEMICAL CORP (US) | 2007-08-29 | — | — | CN | claimed |
| EP-2503878-B1 | DENDRITIC POLYUREA FOR SOLUBILIZING ACTIVE SUBSTANCES OF LOW SOLUBILITY | BASF SE (DE) | 2015-01-28 | — | — | EP | disclosed |
| US-8936902-B2 | Positive-working imageable elements and method of use | EASTMAN KODAK COMPANY (US) | 2015-01-20 | — | — | US | disclosed |
| US-20140341822-A1 | Associative Thickeners Based on Hyperbranched Polymers | BASF SE (DE) | 2014-11-20 | — | — | US | disclosed |
| EP-2739664-A1 | ASSOCIATIVE THICKENERS BASED ON HYPERBRANCHED POLYMERS | BASF SE (DE) | 2014-06-11 | — | — | EP | disclosed |
| US-8728504-B2 | Process for solubilizing hydrophobic active ingredients in aqueous medium | BASF SE (DE) | 2014-05-20 | — | — | US | disclosed |
| WO-2013020820-A1 | ASSOCIATIVE THICKENERS BASED ON HYPERBRANCHED POLYMERS | BASF SE (DE) | 2013-02-14 | — | — | WO | disclosed |
| EP-2531548-A1 | METHOD FOR SOLUBILIZING HYDROPHOBIC ACTIVE INGREDIENTS IN AN AQUEOUS SOLUTION | BASF SE (DE) | 2012-12-12 | — | — | EP | disclosed |
| EP-2503878-A1 | DENDRITIC POLYUREA FOR SOLUBILIZING ACTIVE SUBSTANCES OF LOW SOLUBILITY | BASF SE (DE) | 2012-10-03 | — | — | EP | disclosed |
| WO-2011095449-A1 | METHOD FOR SOLUBILIZING HYDROPHOBIC ACTIVE INGREDIENTS IN AN AQUEOUS SOLUTION | BASF SE (DE) | 2011-08-11 | — | — | WO | disclosed |
| EP-1590326-A2 | SUBSTITUTED ALKYL AMIDO PIPERIDINES | H. Lundbeck A/S (DK) | 2005-11-02 | — | — | EP | disclosed |
| US-20050222360-A1 | Method for the production of highly functional, highly branched polyureas | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-06 | — | — | US | disclosed |
| US-20040186103-A1 | Substituted alkyl amido piperidines | SYNAPTIC PHARMACEUTICAL CORPORATION | 2004-09-23 | — | — | US | disclosed |
| WO-2004064764-A2 | SUBSTITUTED ALKYL AMIDO PIPERIDINES | H. LUNDBECK A/S (DK) | 2004-08-05 | — | — | WO | disclosed |
| US-5684122-A | IMIDIZED MALEIC ANHYDRIDE-OLEFIN COPOLYMER, PHYLLOSILICATE | TOSOH CORPORATION (JP) | 1997-11-04 | — | — | US | disclosed |
| EP-0156210-B1 | CURABLE RESIN COMPOSITIONS BASED ON TERTIARY AMINO GROUP-CONTAINING VINYL POLYMERS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1990-06-13 | — | — | EP | disclosed |
| US-4670521-A | Process for producing tertiary amino group-containing vinyl polymers and curable resin compositions based on these polymers | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1987-06-02 | — | — | US | disclosed |
| US-4634736-A | PAINTS | DAINIPPON INK & CHEMICALS (JP) | 1987-01-06 | — | — | US | disclosed |
| EP-0156210-A2 | Curable resin compositions based on tertiary amino group-containing vinyl polymers | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1985-10-02 | — | — | EP | disclosed |
| US-4446281-A | Modified cis-1,4-polyisoprene rubber, a process for manufacturing the same, and a composition containing the same | KURARAY CO., LTD. (JP) | 1984-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140341822-A1 | Associative Thickeners Based on Hyperbranched Polymers | DSG1, TAF11, UROD | HRH3 1843/4885CHRNB2 3062/4885CHRNB4 2804/4885 |
| US-20040186103-A1 | Substituted alkyl amido piperidines | MCHR1, MCHR2, MC1R | HRH3 129/4885CHRNB2 358/4885CHRNB4 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.